scholarly journals Detection of circulating tumor cells in patients with lung cancer using metallic micro‑cavity array filter: A pilot study

Author(s):  
Hideo Ichimura ◽  
Takeshi Nawa ◽  
Yusuke Yamamoto ◽  
Kei Shimizu ◽  
Keisuke Kobayashi ◽  
...  
2018 ◽  
Vol 38 (1) ◽  
Author(s):  
Mônica Taiane de Macêdo Diaz ◽  
Emne Ali Abdallah ◽  
Milena Shizue Tariki ◽  
Alexcia Camila Braun ◽  
Aldo Lourenço Abbade Dettino ◽  
...  

2020 ◽  
Vol 34 (6) ◽  
Author(s):  
Cheng An ◽  
Guijian Liu ◽  
Shi Cheng ◽  
Bo Pang ◽  
Shipeng Sun ◽  
...  

2014 ◽  
Vol 4 ◽  
Author(s):  
Chao H. Huang ◽  
Jo A. Wick ◽  
Gurusingham Sitta Sittampalam ◽  
Victor Sanjit Nirmalanandhan ◽  
Apar Kishor Ganti ◽  
...  

Human Cell ◽  
2021 ◽  
Author(s):  
Yan Lu ◽  
Yushuang Zheng ◽  
Yuhong Wang ◽  
Dongmei Gu ◽  
Jun Zhang ◽  
...  

AbstractLung cancer is the most fetal malignancy due to the high rate of metastasis and recurrence after treatment. A considerable number of patients with early-stage lung cancer relapse due to overlooked distant metastasis. Circulating tumor cells (CTCs) are tumor cells in blood circulation that originated from primary or metastatic sites, and it has been shown that CTCs are critical for metastasis and prognosis in various type of cancers. Here, we employed novel method to capture, isolate and classify CTC with FlowCell system and analyzed the CTCs from a cohort of 302 individuals. Our results illustrated that FlowCell-enriched CTCs effectively differentiated benign and malignant lung tumor and the total CTC counts increased as the tumor developed. More importantly, we showed that CTCs displayed superior sensitivity and specificity to predict lung cancer metastasis in comparison to conventional circulating biomarkers. Taken together, our data suggested CTCs can be used to assist the diagnosis of lung cancer as well as predict lung cancer metastasis. These findings provide an alternative means to screen early-stage metastasis.


Sign in / Sign up

Export Citation Format

Share Document